# Bancorp 34, Inc.: financial statements, quarterly

BCTF · OTC · CIK 1668340 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bctf.md) · [Financials](/companies/bctf/financials.md) · [Filings](/companies/bctf/filings.md) · [Insiders](/companies/bctf/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bctf/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2022 (2020-06-30) | period not labelled (2022-03-31) | period not labelled (2022-09-30) | period not labelled (2022-12-31) | period not labelled (2023-03-31) | period not labelled (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $k | [1,064](/filings/0001437749-20-015784.md) | not reported | [1,498](/filings/0001552781-23-000490.md) | [2,295 d](/filings/0001552781-24-000084.md) | [2,596](/filings/0001552781-24-000342.md) | [3,066](/filings/0001552781-24-000486.md) | [3,468](/filings/0001552781-24-000598.md) | [3,820 d](/filings/0001552781-25-000058.md) | [4,255](/filings/0001552781-24-000342.md) | [5,653](/filings/0001552781-24-000486.md) | [5,782](/filings/0001552781-24-000598.md) | [5,797 d](/filings/0001552781-25-000058.md) |
| Income tax | $k | [110](/filings/0001437749-20-015784.md) | not reported | [321](/filings/0001552781-23-000490.md) | [(994) d](/filings/0001552781-24-000084.md) | [158](/filings/0001552781-24-000342.md) | [19.0](/filings/0001552781-24-000486.md) | [(603)](/filings/0001552781-24-000598.md) | [(27.0) d](/filings/0001552781-25-000058.md) | [(2,003)](/filings/0001552781-24-000342.md) | [351](/filings/0001552781-24-000486.md) | [477](/filings/0001552781-24-000598.md) | [101 d](/filings/0001552781-25-000058.md) |
| Net income | $k | [502](/filings/0001437749-20-015784.md) | [1,004](/filings/0001552781-23-000490.md) | [1,004](/filings/0001552781-23-000490.md) | [(1,942) d](/filings/0001552781-24-000084.md) | [444](/filings/0001552781-24-000342.md) | [104](/filings/0001552781-24-000486.md) | [(2,275)](/filings/0001552781-24-000598.md) | [(1,676) d](/filings/0001552781-25-000058.md) | [(1,539)](/filings/0001552781-24-000342.md) | [1,505](/filings/0001552781-24-000486.md) | [1,575](/filings/0001552781-24-000598.md) | [148 d](/filings/0001552781-25-000058.md) |
| Diluted EPS | $ per share | [0.17](/filings/0001437749-20-015784.md) | [0.42](/filings/0001552781-23-000490.md) | [0.42](/filings/0001552781-23-000490.md) | not reported | [0.11](/filings/0001552781-24-000342.md) | [0.01](/filings/0001552781-24-000486.md) | [(0.52)](/filings/0001552781-24-000598.md) | not reported | [(0.31)](/filings/0001552781-24-000342.md) | [0.21](/filings/0001552781-24-000486.md) | [0.22](/filings/0001552781-24-000598.md) | not reported |
| Basic EPS | $ per share | [0.17](/filings/0001437749-20-015784.md) | [0.42](/filings/0001552781-23-000490.md) | [0.42](/filings/0001552781-23-000490.md) | not reported | [0.11](/filings/0001552781-24-000342.md) | [0.01](/filings/0001552781-24-000486.md) | [(0.52)](/filings/0001552781-24-000598.md) | not reported | [(0.31)](/filings/0001552781-24-000342.md) | [0.21](/filings/0001552781-24-000486.md) | [0.22](/filings/0001552781-24-000598.md) | not reported |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2021-12-31) | period not labelled (2022-06-30) | period not labelled (2022-09-30) | period not labelled (2022-12-31) | period not labelled (2023-03-31) | period not labelled (2023-06-30) | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | not reported | not reported | not reported | [574](/filings/0001552781-24-000084.md) | not reported | not reported | [581](/filings/0001552781-23-000490.md) | [581](/filings/0001552781-25-000058.md) | [980](/filings/0001552781-24-000342.md) | [922](/filings/0001552781-24-000486.md) | [939](/filings/0001552781-24-000598.md) | [918](/filings/0001552781-25-000058.md) |
| Total liabilities | $m | not reported | not reported | not reported | [525](/filings/0001552781-24-000084.md) | not reported | not reported | [520](/filings/0001552781-23-000490.md) | [521](/filings/0001552781-25-000058.md) | [898](/filings/0001552781-24-000342.md) | [838](/filings/0001552781-24-000486.md) | [852](/filings/0001552781-24-000598.md) | [832](/filings/0001552781-25-000058.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | [43.0](/filings/0001552781-23-000490.md) | [54.0](/filings/0001552781-24-000084.md) | [77.5](/filings/0001552781-24-000342.md) | [57.2](/filings/0001552781-24-000486.md) | [57.2](/filings/0001552781-24-000598.md) | [28.5](/filings/0001552781-25-000058.md) |
| Shareholders' equity | $m | [40.7](/filings/0001552781-24-000084.md) | [37.7](/filings/0001552781-23-000490.md) | [36.3](/filings/0001552781-23-000490.md) | [48.6](/filings/0001552781-25-000058.md) | [64.5](/filings/0001552781-24-000486.md) | [63.7](/filings/0001552781-24-000598.md) | [60.4](/filings/0001552781-24-000598.md) | [60.7](/filings/0001552781-25-000058.md) | [82.2](/filings/0001552781-24-000486.md) | [84.1](/filings/0001552781-24-000598.md) | [87.1](/filings/0001552781-24-000598.md) | [86.5](/filings/0001552781-25-000058.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2019 (2019-12-31) | Q1 FY2022 (2020-03-31) | Q2 FY2022 (2020-06-30) | period not labelled (2022-12-31) | period not labelled (2023-03-31) | period not labelled (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [2,374 d](/filings/0001437749-20-002924.md) | [733](/filings/0001437749-20-009457.md) | [141 d](/filings/0001437749-20-015784.md) | [6,479 d](/filings/0001552781-24-000084.md) | [759](/filings/0001552781-24-000342.md) | [1,499 d](/filings/0001552781-24-000486.md) | [2,046 d](/filings/0001552781-24-000598.md) | [(3,394) d](/filings/0001552781-25-000058.md) | [(1,244)](/filings/0001552781-24-000342.md) | [1,315 d](/filings/0001552781-24-000486.md) | [2,277 d](/filings/0001552781-24-000598.md) | [626 d](/filings/0001552781-25-000058.md) |
| Capital expenditure | $k | not reported | not reported | not reported | [266 d](/filings/0001552781-24-000084.md) | [38.0](/filings/0001552781-24-000342.md) | [57.0 d](/filings/0001552781-24-000486.md) | [5.0 d](/filings/0001552781-24-000598.md) | [126 d](/filings/0001552781-25-000058.md) | [100](/filings/0001552781-24-000342.md) | [33.0 d](/filings/0001552781-24-000486.md) | [109 d](/filings/0001552781-24-000598.md) | [258 d](/filings/0001552781-25-000058.md) |
| Dividends paid | $k | [158 d](/filings/0001437749-20-002924.md) | [158](/filings/0001437749-20-009457.md) | [158 d](/filings/0001437749-20-015784.md) | [174 d](/filings/0001552781-24-000084.md) | [328](/filings/0001552781-24-000342.md) | [329 d](/filings/0001552781-24-000486.md) | [(1.0) d](/filings/0001552781-24-000598.md) | [0.0 d](/filings/0001552781-25-000058.md) | not reported | not reported | not reported | not reported |
| Share repurchases | $k | [0.0 d](/filings/0001437749-20-002924.md) | not reported | not reported | [0.0 d](/filings/0001552781-24-000084.md) | [210](/filings/0001552781-24-000342.md) | [0.0 d](/filings/0001552781-24-000486.md) | [0.0 d](/filings/0001552781-24-000598.md) | [0.0 d](/filings/0001552781-25-000058.md) | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends, us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2018 (2018-03-31) | Q2 FY2018 (2018-06-30) | Q3 FY2018 (2018-09-30) | Q1 FY2019 (2019-03-31) | Q2 FY2019 (2019-06-30) | Q3 FY2019 (2019-09-30) | Q1 FY2022 (2020-03-31) | Q2 FY2022 (2020-06-30) | period not labelled (2022-03-31) | Q3 FY2023 (2023-09-30) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [3,207](/filings/0001437749-19-008052.md) | [3,164](/filings/0001437749-19-016077.md) | [3,166](/filings/0001437749-19-020667.md) | [3,145](/filings/0001437749-20-009457.md) | [3,141](/filings/0001437749-20-015784.md) | [3,056](/filings/0001437749-19-020667.md) | [3,005](/filings/0001437749-20-009457.md) | [2,999](/filings/0001437749-20-015784.md) | [2,364](/filings/0001552781-23-000490.md) | [4,375](/filings/0001552781-23-000490.md) | [820](/filings/0001552781-24-000486.md) | [820](/filings/0001552781-24-000598.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 6,665,415 at 2025-03-06, from the cover of the [10-K filed 2025-03-06](/filings/0001552781-25-000058.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.